Seoul-based medical equipment maker Samsung Medison has not too long ago agreed to totally buy Sonio, a foetal ultrasound AI firm in France, for 126 billion gained ($92 million).
The four-year-old French startup has been growing IT options for obstetrics and gynaecology ultrasound, helping medical professionals in documenting and evaluating ultrasound examinations.
Final 12 months, it obtained the US FDA 510(okay) clearance for Sonio Detect, which is claimed to be the primary machine-agnostic AI assistant software program that automates ultrasound reporting and gives picture high quality management.
WHY IT MATTERS
“Collaboration with Sonio will carry collectively best-in-class ultrasound AI know-how and reporting capabilities to carry a paradigm shift within the prenatal ultrasound examination,” stated Samsung Medison CEO Yong Kwan Kim.
With Sonio on its portfolio, Samsung Medison joins a rising record of ultrasound system suppliers that are actually enabled by AI. In 2022, ultrasound machine maker Exo additionally purchased an ultrasound AI supplier, Medo, to supply superior imaging capabilities. Early final 12 months, GE HealthCare acquired Caption Well being, a giant title in ultrasound AI.
Upon completion of their transaction, Sonio will stay an impartial firm based mostly in France. It should proceed with its industrial development independently whereas sustaining the compatibility of its merchandise with any ultrasound machine techniques.
“Along with shut collaboration with Samsung Medison, as an impartial firm, Sonio will proceed to advance medical reporting know-how and diagnostic software program globally, together with for underserved areas in healthcare,” added Sonio CEO Cécile Brosset.
The closing of their transaction remains to be topic to regulatory approvals, together with that of the French Ministry of the Financial system and Finance.
THE LARGER TREND
Sonio first partnered with Samsung by means of Samsung Healthcare France in 2021. Their collaboration aimed to verify its AI answer for being pregnant monitoring and prenatal analysis.
Searching for additional enlargement throughout Asia, Sonio additionally tied up with biotechnology agency LifeCell final 12 months to advertise its AI providing within the Indian market, the place a few hundred infants are born each two minutes.
In the meantime, Sonio raised $14 million in Collection A funding final 12 months for its industrial launch in the US. The funds had been additionally supposed to support its R&D efforts and adapt its AI for transportable ultrasound gadgets and level of care.
